Trial Profile
Phase Ib multiple-dose trial of ARRY 162 in patients with rheumatoid arthritis who are receiving methotrexate.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2008
Price :
$35
*
At a glance
- Drugs Binimetinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Array BioPharma
- 06 May 2008 Status changed from in progress to completed, according to a media release from Array BioPharma.
- 14 Nov 2007 New trial record.